David L. Katz, MD, MPH, FACPM, FACP is the founding director of Yale University’s Prevention Research Center; President of the American College of Lifestyle Medicine; Editor-in-Chief of the journal, Childhood Obesity; Chief Science Officer for NuVal LLC; and director of the Integrative Medicine Center at Griffin Hospital. A clinician, researcher, author, inventor, journalist, and media personality, Dr. Katz is the recipient of numerous awards and recognitions, including an honorary doctoral degree; widely supported nominations for the position of U.S. Surgeon General; recognition by Greatist.com as one of the 100 most influential people in health and fitness in the world for the past 3 years; and inclusion by LinkedIN as one of the original 150 INfluencers. He has authored over 200 scientific papers and chapters, 15 books, and well over 1,000 columns and blogs- with a resulting social media following of roughly 500,000. A two-time diplomate of the American Board of Internal Medicine, and a board-certified specialist in Preventive Medicine/Public Health, he is recognized globally for expertise in nutrition, weight management and the prevention of chronic disease. Dr. Katz has delivered addresses in numerous countries on four continents, and has been acclaimed by colleagues as the “poet laureate” of health promotion. http://www.davidkatzmd.com/default.aspx
Weight loss drugs are not the solution to achieve sustainable weight loss and improve overall health.
Up to a million more people could be offered weight loss surgery on the NHS after NICE lowered the threshold for which patients are eligible for bariatric surgery. David Haslam, GP and chairman of the National Obesity Forum UK, and David Katz, director, Yale University Prevention Research Center, discuss the merits of the decision, and the use of bariatric